Literature DB >> 24102378

Epigenetic activation of mouse ganglioside synthase genes: implications for neurogenesis.

Yi-Tzang Tsai1, Robert K Yu.   

Abstract

The quantity and expression pattern of gangliosides in mammalian brain change drastically during development and are mainly regulated through stage-specific expression of ganglioside synthase genes. Despite extensive investigations in the past, it remains largely unclear how the transcriptional activation of the genes encoding glycosyltransferases is regulated. Here, we show that in the neuronogenic cultures of mouse embryonic brain-derived neuroepithelial cells, histone modifications including acetylated histone H3 and histone H4, but not histone H3 trimethylation at lysine 27 of two genes encoding two key regulatory GTs, namely, N-acetylgalactosaminyltransferase I and sialyltransferase II, were extensively and gradually enhanced, respectively. As a consequence, the level of each GT mRNA was increased correspondingly. Hyperacetylation of histones on the GalNAcT promoter resulted in recruitment of the trans-activation factors Sp2 and AP-1 when cellular histone deacetylases 1 and 2 were knocked down with RNA interference or inhibited by treatment with valproic acid. Moreover, epigenetic activation of GalNAcT was also detected, as accompanied by a pronounced induction of neural differentiation in primary neuroepithelium culture responding to an exogenous supplement of ganglioside GM1, a downstream product of the gene's encoding enzyme. Our findings thus provide direct evidence of novel pathways for ganglioside expression via the epigenetic up-regulation of ganglioside synthase genes during neural development.
© 2013 International Society for Neurochemistry.

Entities:  

Keywords:  brain development; epigenetic regulation; ganglioside; glycosyltransferase; neural stem cell

Mesh:

Substances:

Year:  2013        PMID: 24102378     DOI: 10.1111/jnc.12456

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

Review 2.  Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells.

Authors:  Yutaka Itokazu; Yi-Tzang Tsai; Robert K Yu
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

3.  Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers.

Authors:  Yasuhiko Kizuka; Shinobu Kitazume; Kyohei Okahara; Alejandro Villagra; Eduardo M Sotomayor; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

Review 4.  Gangliosides in Nerve Cell Specification.

Authors:  Yutaka Itokazu; Jing Wang; Robert K Yu
Journal:  Prog Mol Biol Transl Sci       Date:  2018-01-17       Impact factor: 3.622

5.  Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.

Authors:  Avisek Banerjee; Barun Mahata; Arjun Dhir; Tapan Kumar Mandal; Kaushik Biswas
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

6.  Induction of Glycosphingolipid GM3 Expression by Valproic Acid Suppresses Cancer Cell Growth.

Authors:  Nagako Kawashima; Yoshiyuki Nishimiya; Shouta Takahata; Ken-Ichi Nakayama
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

Review 7.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

8.  Ganglioside Microdomains on Cellular and Intracellular Membranes Regulate Neuronal Cell Fate Determination.

Authors:  Yutaka Itokazu; Robert K Yu
Journal:  Adv Neurobiol       Date:  2023

9.  GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells.

Authors:  Yi-Tzang Tsai; Yutaka Itokazu; Robert K Yu
Journal:  Neurochem Res       Date:  2015-10-24       Impact factor: 3.996

10.  Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse.

Authors:  Yutaka Itokazu; Takahiro Fuchigami; John C Morgan; Robert K Yu
Journal:  Mol Ther       Date:  2021-06-08       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.